![Thomas Schluep](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Schluep
Nessuna posizione attualmente
Profilo
Dr. Thomas Schluep is Chief Scientific Officer at Calando Pharmaceuticals, Inc. and Vice President-Program Management at Arrowhead Research Corp.
Dr. Schluep was previously employed as Chief Scientific Officer by Insert Therapeutics, Inc., a Principal by Canji, Inc., and a Principal by Massachusetts Institute of Technology.
He received his graduate degree from the Swiss Federal Institute of Technology and a doctorate degree from the Swiss Federal Institute of Technology.
Precedenti posizioni note di Thomas Schluep
| Società | Posizione | Fine |
|---|---|---|
Insert Therapeutics, Inc.
 Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops therapeutic products | Direttore Tecnico/Scientifico/R&S | 08/09/2008 |
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
Canji, Inc.
 Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Corporate Officer/Principal | - |
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Thomas Schluep
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Health Services |
Insert Therapeutics, Inc.
Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops therapeutic products | Commercial Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
